CEP
NPSP

Chicago Equity Partners’s NPS PHARMACEUTICALS INC NPSP Stock Holding History

Chicago Equity Partners’s Portfolio NPSP Stock Details NPSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-11,400
Closed -$341K – 538
2014
Q1 		$341K Buy
11,400
+350
+3% +$12.1K 0.01% 362
2013
Q4 		$335K Sell
11,050
-1,975
-15% -$54.4K 0.01% 347
2013
Q3 		$414K Buy
+13,025
New +$299K 0.01% 351

Other funds holding NPSP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Chicago Equity Partners's NPSP Position: Q2 2014 in Review

Chicago Equity Partners sold out of NPS PHARMACEUTICALS INC (NPSP) in Q2 2014, closing a stake of 11,400 shares — an estimated $341K sold.

Chicago Equity Partners first reported a position in NPSP in Q3 2013 and held it in 3 quarters. The position peaked at $414K in Q3 2013. 215 funds tracked by Wall St. Rank hold NPSP as of Q2 2014.

  • Chicago Equity Partners reported no remaining NPS PHARMACEUTICALS INC position as of Q2 2014 after selling out during the quarter.
  • Chicago Equity Partners sold 11,400 NPS PHARMACEUTICALS INC shares in Q2 2014, an estimated $341K.
  • Chicago Equity Partners first reported a position in NPS PHARMACEUTICALS INC in Q3 2013 and held it in 3 quarters.
  • Chicago Equity Partners's NPS PHARMACEUTICALS INC position peaked at $414K in Q3 2013.
  • 215 funds tracked by Wall St. Rank held NPS PHARMACEUTICALS INC as of Q2 2014.

Based on Chicago Equity Partners's 13F filing for Q2 2014, filed 1 Aug 2014.